Curasight

Curasight – a Danish biotech company with shares and warrants listed on Spotlight Stock Market. The first day of trading was 8th of October 2020. Comprend helped them with their new corporate website.

The Danish biotech company Curasight has developed an imaging technology that provides less evasive and improved diagnosis of multiple cancers. Their team are the pioneers behind the novel uPAR Theranostics technology – a technology that minimises irradiation of healthy tissue by combining targeted uTREAT® radiation therapy, with precision uTRACE® diagnostics. Several clinical studies are in phase II, in partnership with Rigshospitalet – the Danish University Hospital of Copenhagen.

Challenge

When Curasight made the decision to go public via an Initial Public Offering (IPO), there were several things that had to be put in place to ensure full compliance and to enable them to communicate effectively and efficiently with investors and journalists. The listing process not only meant meeting regulatory requirements but also addressing new stakeholders' expectations.

Their existing website was not fit for the purpose of being able to handle the requirements of a listed company, and they also needed a new 'Investor Relations' section to present the financial and regulatory information required for going public.

Solution

Professional advice on website planning, content structure and what is required by a listed company. A stable and flexible platform: we migrated Curasight's website to our platform Website as a Service (WaaS). The platform provides capabilities suitable for listed companies, including integration with third party solutions for share price information, ownership structure as well as publishing of press releases and reports. New functionality and an intuitive content structure to cater for needs related to Investor Relations, and to provide the necessary content including press releases and report archives.

Results

In only 3.5 weeks we helped Curasight migrate their existing website content to our WaaS platform, providing them with a stable CMS in which they could then continue to develop the content on their own, supported by Comprend. The new website is much more comprehensive from functionality to content to structure, meets the needs of all stakeholders, complies with stock trading rules and corporate governance, and supports daily business communications. Since the launch of the new website, we have continued to work with Curasight to further improve their digital presence, including impact mapping exercises to help guide their order of prioritisation for future site enhancements. We will continue to adjust the content and structure to meet the needs of their prioritised target groups and are proud to have gained a satisfied and long-term partner in the process.

Curasight was awarded two honourable mentions in Best IPO 2020 by the Swedish business magazine Affärsvärlden’s independent IPO Guide.

Are you ready? We are

Regardless if you are ready or not, we are. We help you get ready and drive your communication into the future.

Let's meet
Johan Sixtensson

Johan Sixtensson

Client Director

johan.sixtensson@comprend.com

+46 76 109 05 42

Berulv Tøndel

Berulv Tøndel

Client Director

berulv.tondel@comprend.com

+46 76 109 05 28

Cookies
This website uses cookies as described in our Cookie policy. To see what cookies we serve and set your own preferences, please use your web browser's settings. Otherwise, if you agree to our use of cookies, please continue to use our website. Cookie policy